Skip to main content
. 2023 Nov 15;37(1):364–375. doi: 10.1007/s13577-023-01003-4

Fig. 4.

Fig. 4

Cell viability of CBC3T-1 cells after 72 h of exposure to anticancer drugs. a–e Sensitivity of CBC3T-1 cells to cisplatin, oxaliplatin, gemcitabine, paclitaxel, and 5-FU